🇺🇸 FDA
Patent

US 12214014

Methods for scar reduction by converting scar fibroblasts into adipocytes with hair follicle-derived signals

granted A61KA61K35/36A61K38/1875

Quick answer

US patent 12214014 (Methods for scar reduction by converting scar fibroblasts into adipocytes with hair follicle-derived signals) held by The Regents of the University of California expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K35/36, A61K38/1875, A61K45/06, A61K9/0014